Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,152
Closed -$284K 112
2024
Q1
$284K Buy
2,152
+3
+0.1% +$370 0.06% 84
2023
Q4
$234K Buy
2,149
+39
+2% +$4.05K 0.05% 96
2023
Q3
$217K Sell
2,110
-293
-12% -$31.6K 0.05% 99
2023
Q2
$277K Buy
2,403
+237
+11% +$26.9K 0.06% 86
2023
Q1
$230K Sell
2,166
-126
-5% -$13.6K 0.06% 98
2022
Q4
$254K Buy
+2,292
New +$234K 0.07% 85

Other funds holding MRK

NBW Capital's MRK Position: Q2 2024 in Review

NBW Capital sold out of Merck (MRK) in Q2 2024, closing a stake of 2,152 shares — an estimated $284K sold.

NBW Capital first reported a position in MRK in Q4 2022 and held it in 6 quarters. The position peaked at $284K in Q1 2024. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • NBW Capital reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • NBW Capital sold 2,152 Merck shares in Q2 2024, an estimated $284K.
  • NBW Capital first reported a position in Merck in Q4 2022 and held it in 6 quarters.
  • NBW Capital's Merck position peaked at $284K in Q1 2024.
  • 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on NBW Capital's 13F filing for Q2 2024, filed 14 Aug 2024.